About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clinical Trials Prostate CancerMaryland

Prostate Cancer Clinical Trials in Maryland

Find 690 clinical trials for prostate cancer near Maryland. Connect with research centers in your area.

All Prostate Cancer trials nationwide All trials in Maryland

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 221-240 of 690 trials

CompletedSurvivorship Promotion In Reducing IGF-1 TrialThis is a prospective, single-center randomized trial with three arms, and an allocation ratio of 1:1:1.NCT02431676·Baltimore, Maryland RecruitingTesting Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate CancerThis phase III trial compares stereotactic body radiation therapy (SBRT), (five treatments over two weeks using a higher dose per treatment) to usual radiation therapy (20 to 45…NCT05946213·Birmingham, Alabama and 435 others

Prostate Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

UnknownClariCore Optical Biopsy System Used in TRUS (Trans-Rectal Ultrasound)-Guided Prostrate BiopsyThe purpose of the study is to collect information on prostrate biopsy tissue for use in developing a method determining the difference in normal and cancerous prostrate tissue…NCT02928640·Denver, Colorado and 4 others

RecruitingFollow-Up Study of Subjects Previously Enrolled in Poxviral Vector Gene Transfer StudiesThis study aims to provide long-term follow-up care of patients previously enrolled in a vaccine study that involved poxviral vectors.NCT00451022·Bethesda, Maryland

TerminatedDose Escalation and Dose Expansion Study of GSK525762 in Combination With Androgen Deprivation Therapy in Participants With Castrate-resistant Prostate CancerThis study aims to evaluate the combination of GSK525762 with other agents that have been shown to be effective in the treatment of CRPC or metastatic (m)CRPC.NCT03150056·Los Angeles, California and 19 others

SuspendedPilot Study to Investigate Magnetic Resonance (MR) Image Guided Focal Therapy in Prostate CancerBackground: The ability to treat early prostate cancer is still limited. Thermal ablation methods are being tested for focal prostate cancer therapy.NCT04808427·Bethesda, Maryland

CompletedStudy to Evaluate the Safety, Pharmacokinetics, Tissue Distribution, Metabolism and Dosimetry of Two Prostate Cancer Imaging AgentsThis is a single blinded, randomized, cross-over design. Up to 12 patients will be randomly administered a single 10.0 mCi dose of 123I-MIP-1072 or 123I-MIP-1095 (study drugs).NCT00712829·Baltimore, Maryland and 2 others

CompletedDocetaxel and PROSTVAC for Metastatic Castration-Sensitive Prostate CancerBackground: Metastatic castrate-sensitive prostate cancer is cancer that has spread beyond the prostate area.NCT02649855·Bethesda, Maryland

Active not recruitingPYLARIFY® PET/CT or PET/MRI in Men With Favorable Intermediate Risk (FIR) Prostate CancerThe purpose of this study is to learn whether PYLARIFY PET imaging (study scan) can safely and accurately detect the presence or absence of prostate cancer growing beyond the…NCT06074510·Birmingham, Alabama and 13 others

CompletedProstate SBRT for Locally Recurrent Prostate Cancer After Prior RadiotherapyBackground: Prostate cancer is the second leading cause of cancer death in United States (U.S.) men.NCT03253744·Bethesda, Maryland

WithdrawnA Pilot Study of 123I-MIP-1072 SPECT/CT Imaging With Optional Compact Gamma Camera Probe Imaging in Men With Prostate Cancer Undergoing ProstatectomyThis is a single arm, open label study of up to 20 patients with prostate cancer scheduled for prostatectomy at the NIH Clinical Center.NCT01279785·Bethesda, Maryland

Active not recruitingStudy of Capivasertib + Docetaxel vs Placebo + Docetaxel as Treatment for Metastatic Castration Resistant Prostate Cancer (mCRPC)This study will assess the efficacy and safety of capivasertib plus docetaxel versus placebo plus docetaxel in participants with metastatic castration resistant prostate cancer…NCT05348577·Yuma, Arizona and 216 others

RecruitingMen at High Genetic Risk for Prostate CancerBackground: Research studies have shown that genetic changes and family history may increase a man s risk for prostate cancer.NCT03805919·Bethesda, Maryland

WithdrawnViberect Penile Vibratory Stimulation to Enhance Recovery of Erectile Function and Urinary Continence Post-ProstatectomyThe purpose of this study is to evaluate whether using penile vibratory stimulation with the Viberect handheld device can help the recovery of erections and urinary control after…NCT01718704·Baltimore, Maryland and 1 other

CompletedA Pre-surgical Study of LDE225 in Men With High-risk Localized Prostate CancerThis trial is designed as a randomized two-arm (LDE225 vs. observation groups) open-label prospective clinical trial in men with localized high-risk prostate cancer undergoing…NCT02111187·Baltimore, Maryland

CompletedZoledronate in Treating Patients With Solid Tumors That Have Spread to the BoneRATIONALE: Zoledronate may help to relieve some of the symptoms caused by bone metastases.NCT00003884·Birmingham, Alabama and 54 others

TerminatedAllogeneic Human Bone Marrow Derived Mesenchymal Stem Cells in Localized Prostate CancerThe objective of this study is to determine if systemically infused allogeneic bone marrow derived mesenchymal stem cells (MSC) home to sites of prostate cancer in men with…NCT01983709·Baltimore, Maryland

CompletedCOMbination of Bipolar Androgen Therapy and NivolumabSingle arm, multicenter, open-label Phase II study of the effects of parenteral testosterone in combination with nivolumab in men with metastatic castration-resistant prostate…NCT03554317·San Francisco, California and 2 others

RecruitingZEN003694 and Enzalutamide Versus Enzalutamide Monotherapy in Metastatic Castration-Resistant Prostate CancerThis is an open-label, randomized, Phase 2b study of ZEN003694 in combination with enzalutamide vs. enzalutamide monotherapy in patients with mCRPC who have progressed on prior…NCT04986423·Los Angeles, California and 30 others

CompletedRadiation Therapy With or Without Bicalutamide for Recurrent pT3N0 Prostate Cancer After Radical ProstatectomyRATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells. Androgens can stimulate the growth of prostate cancer cells.NCT00002874·Birmingham, Alabama and 239 others

PreviousPage 12 of 35Next

Other Conditions in Maryland

Breast Cancer Lung Cancer Colorectal Cancer Melanoma Leukemia Lymphoma